000 | 01916cam a22003734a 4500 | ||
---|---|---|---|
999 |
_c4323 _d4323 |
||
001 | 56982354 | ||
003 | OCoLC | ||
005 | 20180423085539.0 | ||
008 | 041104s2006 nyua b 001 0 eng | ||
010 |
_a2004063122 _z2005050545 |
||
020 | _a0071422803 | ||
040 |
_aDLC _cDLC _dBAKER _dCOU _dJDR _dC#P _dMXC |
||
042 | _apcc | ||
050 | 0 | 0 |
_aRM300 _b.G644 2006 |
082 | 0 | 0 |
_a615.7 _222 |
100 |
_aGoodman, Louis Sanford, _d1906- |
||
245 | 0 | 0 | _aGoodman & Gilman's the pharmacological basis of therapeutics |
246 | 3 | 0 | _aPharmacological basis of therapeutics |
246 | 3 | _aGoodman and Gilman's the pharmacological basis of therapeutics | |
250 |
_a11th ed. / _beditor, Laurence L. Brunton ; associate editors, John S. Lazo, Keith L. Parker |
||
260 |
_aNew York : _bMcGraw-Hill, _cc2006 |
||
300 |
_axxiii, 2021 p. : _bill. ; _c26 cm |
||
504 | _aIncludes bibliographical references and index | ||
505 | 0 | 0 |
_gSect. I _tGeneral principles -- _gSect. II _tDrugs acting at synaptic and neuroeffector junctional sites -- _gSect. III _tDrugs acting on the central nervous system -- _gSect. IV _tAutacoids: drug therapy of inflammation -- _gSect. V _tDrugs affecting renal and cardiovascular function -- _gSect. VI _tDrugs affecting gastrointestinal function -- _gSect. VII _tChemotherapy of parasitic infections -- _gSect. VIII _tChemotherapy of microbial diseases -- _gSect. IX _tChemotherapy of neoplastic diseases -- _gSect. X _tImmunomodulators -- _gSect. XI _tDrugs acting on the blood and the blood-forming organs -- _gSect. XII _tHormones and hormone antagonists -- _gSect. XIII _tDermatology -- _gSect. XIV _tOphthalmology -- _gSect. XV _tToxicology -- _tAppendices |
650 | 0 | _aPharmacology | |
650 | 0 | _aTherapeutics | |
650 | 1 | 2 | _aPharmacology |
650 | 1 | 2 | _aDrug Therapy |
700 | 1 |
_aGilman, Alfred, _d1908- |
|
700 | 1 | _aBrunton, Laurence L | |
700 | 1 | _aLazo, John S | |
700 | 1 | _aParker, Keith L | |
942 |
_2ddc _cBK |